DSS Inc

Análisis de la acción DSS Inc (DSS)

$0.610

+0.006 (+1.04%)Al cierre

Loading chart…
Máximo
0.614
Apertura
0.604
Precio medio ponderado por volumen
0.61
Volumen
3.65K
Capitalización
12.39M
Mínimo
0.604
Importe
2.22K
EV/EBITDA, TTM
0.00

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

www.dssworld.com

Análisis de IA of DSS Inc (DSS)

Vender

DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.

Métricas de valoración

El PER previsto actual de DSS Inc (DSS) es 0.00, frente a su media de 5 años de -1.44.

PER previsto

Sobrevalorado
Media 5A P/E
-1.44
P/E actual
0.00
Sobrevalorada
-0.57
Infravalorada
-2.30

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-5.86
EV/EBITDA actual
0.00
Sobrevalorada
1.05
Infravalorada
-12.76

Precio/ventas previsto

Infravalorado
Media 5A P/S
0.66
P/S actual
0.00
Sobrevalorada
1.07
Infravalorada
0.25

Escenarios de precio de Alphio AI para DSS

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%DSS

$0.63

Precio del escenario

B

Base

Base · 50%DSS

$0.63

Precio del escenario

B

Bajista

Bajista · 25%DSS

$0.61

Precio del escenario

Cronología de eventos

2026-09-04 (ET)

09:00:00

DSS, Inc. Cancels Proposed Public Offering

2026-09-03 (ET)

21:00:00

DSS Commences Public Offering of Common Stock

2026-05-08 (ET)

17:10:00

DSS Annual Report Contains Going Concern Audit Opinion

2026-02-04 (ET)

08:40:00

DSS Prices Public Offering Expected to Raise $1M

2026-02-03 (ET)

20:30:00

Aegis Capital Acts as Sole Underwriter for Offering

Noticias

Preguntas frecuentes sobre DSS, respondidas por Alphio AI

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing. It operates in the Basic Materials sector (PAPERBOARD CONTAINERS & BOXES industry).

DSS Inc is not a good buy right now due to significant financial losses and negative trends. The current price is $0.61, and the company has a forward P/E ratio of 0, indicating a lack of earnings potential. Additionally, the gross margin is negative at -25.39%, which reflects ongoing profitability issues. The main risk is the high debt-to-equity ratio of 439.61%, indicating potential solvency concerns.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar